aflibercept

The drug is prescribed to adults for the treatment of wet age-related macular degeneration, macular edema due to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.

Form: solution for injection

ATC: S01LA05

Manufacturer: Bayer AG (manufacturing (including sterile filtration, filling - primary packaging), secondary packaging, batch control, responsible for batch release for vials, labeling, blister packaging, sterilization, secondary packaging, production control, quality control, responsible for batch release for pre-filled syringes; quality control; quality control for pre-filled syringes, quality control (only test for mechanical inclusions) for vials)